Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy.

Serum cytokine levels and mononuclear cell subpopulations in the spleen and peripheral blood of patients with visceral leishmaniasis before and after antimony therapy were analyzed. The percentages of activated monocytes/macrophages, T cells, and possibly B cells; of gamma/delta T cell receptor (TCR)-bearing T cells; of CD4- CD8- alpha/beta TCR-bearing T cells; and serum levels of tumor necrosis factor-alpha (TNF alpha), interferon-gamma (IFN-gamma), and interleukin-6 (IL-6) were high in patients with active visceral leishmaniasis. The proportion of both helper and suppressor CD4+ cells and of cells with NK and cytotoxic T phenotypes were depressed.

Human B-lymphopoiesis is supported by bone marrow-derived stromal cells.

We have recently reported an in vitro culture system that allows the clonal growth and differentiation of normal human bone marrow B-lineage cells. In the report presented here, we have used this B-cell colony assay to study the influence of cellular components of the human bone marrow microenvironment on B-lymphopoiesis. It is demonstrated that bone marrow stromal cells were able to provide all the necessary requirements for the growth and differentiation of B-lineage cells under the conditions of the B-cell colony assay.

Interleukins 1, 4 and 6 induce the colony formation of human bone marrow B lineage cells.

An agar-based, B cell colony assay (McGinnes, K. et al., Blood 1990.

B-lineage colonies from normal, human bone marrow are initiated by B cells and their progenitors.

We have recently described a reproducible method whereby colonies containing cells that secrete immunoglobulin (Ig) can be grown from normal, human, adult bone marrow samples. The present report characterizes the cells that initiate these colonies. It is shown that all clonogenic cells express the CD19 surface antigen, as removal of these cells before plating in the B-cell colony assay abolished the subsequent growth of plaque-forming, B-lineage colonies.

Growth and detection of human bone marrow B-lineage colonies.

A reproducible method for growing normal human bone marrow B-lineage colonies in agar is described. The clonogenic cells require a rich medium, Opti-MEM (GIBCO/BRL, Burlington, Ontario, Canada), and a source of T-cell-derived factors for growth. The conditions described appear to be limiting for the colony progenitor, suggesting assay clonality.

Effects of interferon on natural killer (NK) cells assessed by fluorescent probes and flow cytometry.

The effects of interferon-alpha and -gamma (IFN) on natural killer (NK) cells was investigated by labelling cells with fluorescent membrane and intracellular probes and analysing these by flow cytometry. Peripheral blood mononuclear cells (PBMCs), sorted NK cells and non-NK cells were labelled with one of the fluorescent probes, 3,3'-dihexyloxacarbocyanine (DiOC6(3], N-phenyl-1-naphthylamine (NPN) or Quin 2, subsequent to incubation with IFN-alpha or IFN-gamma and the change in their fluorescence was monitored by flow cytometry. NK activity after treatment with IFN-alpha or -gamma was also monitored in parallel using a standard 51Cr-release assay.

Effect of interferon on the in vitro synthesis of paraprotein by plasma cells in myeloma.

The aim of this study was to determine the effects of interferon on in vitro immunoglobulin synthesis by the plasma cells of patients with multiple myeloma. Bone marrow cultures were set up in the presence of media alone or alpha-interferon. Supernatants were harvested over a 24-hour period and assayed for paraprotein immunoglobulin synthesis using radio-immunoassays developed in this department.

The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients.

The aim of this study was to determine the effect of radiotherapy on peripheral blood natural killer (NK)-cell number and activity in 15 patients with cancer, prior to the commencement and at the completion of radiotherapy. The following observations were made. Prior to radiotherapy NK activity could not be correlated with the stage of malignancy.

A fluorescence NK assay using flow cytometry.

A flow cytometric NK assay was developed in which the K562 targets were labelled with the fluorogenic substrate, carboxyfluorescein diacetate (c'FDA). This new assay compared favourably with results obtained using the conventional 51Cr-release assay. c'FDA was not toxic to target cells and did not inhibit lysis.